{
    "code": "02022409",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022409",
    "time": "2019-11-08 03:02:52",
    "許可證字號": "衛署藥輸字第022409號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/02\/23",
    "發證日期": "88\/02\/23",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202240900",
    "中文品名": "截瘤達錠５００毫克",
    "英文品名": "XELODA TABLETS 500MG",
    "適應症": "乳癌：XELODA與DOCETAXEL併用於治療對ANTHRACYCLINE化學治療無效之局部晚期或轉移性乳癌病患。XELODA亦可單獨用於對紫杉醇（TAXANE）及ANTHRACYCLINE化學治療無效，或無法使用ANTHRACYCLINE治療之局部晚期或轉移性乳癌病患。\r\n結腸癌或大腸(結腸直腸)癌：XELODA可作為第三期結腸癌患者手術後的輔助性療法。XELODA可治療轉移性大腸(結腸直腸)癌病患。胃癌：XELODA合併PLATINUM可使用於晚期胃癌之第一線治療。",
    "劑型": "116膜衣錠",
    "包裝": "20-1000粒瓶裝 鋁箔盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "CAPECITABINE",
    "主製造廠": {
        "申請商名稱": "1901701100  羅氏大藥廠股份有限公司",
        "申請商地址": "台北市信義區松仁路100號40樓、40樓之1、41樓之1",
        "主製造廠": "",
        "製造廠名稱": "FDE0364100  EXCELLA GMBH &amp; CO. KG"
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FCH0093000  F.HOFFMANN-LA ROCHE LTD.",
            "製造廠廠址": "GRENZACHERSTRASSE 124 CH-4070 BASEL,SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        },
        {
            "製造廠名稱": "FCH0208000  F.HOFFMANN-LA ROCHE LTD.",
            "製造廠廠址": "WURMISWEG, CH-4303 KAISERAUGST, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "包裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200037200",
            "成分名稱": "CAPECITABINE",
            "含量描述": "500",
            "含量": "500.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "淺灰紅",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "橢圓形",
        "標記一": "XELODA",
        "標記二": "500"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Xeloda 500mg_Tab_IMAGES-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022409&Seq=437&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Xeloda 中文仿單_CDS 15.0_0619-XEL-01_148x840mm_排-108-07-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022409&Seq=042&Type=9"
        },
        {
            "title": "Xeloda 500mg_024409-1-CTN-05-108-04-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022409&Seq=005&Type=8"
        },
        {
            "title": "Xeloda 500mg_鋁箔_10155912-107-07-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022409&Seq=004&Type=8"
        },
        {
            "title": "Xeloda 500_外盒_024409-1-CTN-04-107-07-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022409&Seq=003&Type=8"
        }
    ]
}